Drug formulation technologists are specialized experts who focus on the development and refinement of pharmaceutical products to ensure that drugs deliver their intended therapeutic effects safely and efficiently. Their responsibilities include designing formulations that balance drug stability, solubility, and bioavailability while maintaining patient compliance. They work with a range of dosage forms such as tablets, capsules, injectables, and topical applications, selecting appropriate excipients and optimizing processing parameters. By using advanced techniques and scientific knowledge, these technologists ensure that the final drug product meets rigorous quality standards and regulatory requirements.
Besides formulation development, drug formulation technologists are involved in scaling up processes from the laboratory to commercial manufacturing, ensuring reproducibility and cost-effectiveness. They conduct thorough evaluations, including stability testing, dissolution profiling, and compatibility assessments, to guarantee product performance throughout its shelf life. Collaboration with cross-functional teams—such as regulatory affairs, quality control, and production—is essential to address challenges and accelerate time-to-market. As the pharmaceutical landscape evolves with emerging technologies like controlled-release systems and nanocarriers, drug formulation technologists continue to play a pivotal role in advancing drug delivery science and improving patient outcomes worldwide. Their expertise is crucial in driving innovation and ensuring that new medicines reach patients safely and efficiently. Ultimately, their work helps transform scientific discoveries into practical treatments that improve global health.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand